Which of the following antiviral drugs against Covid will be approved first by the FDA?

FutuurClosedCheck availabilityVerified resolution data

This market resolved: Pfizer's (21%)

Resolved: Dec 23, 2021, 6:25 PM

Provider-verified resolution

CoinRithm has provider-backed winner and settlement-time evidence for this market.

Data quality warningStale dataNot meaningfully pricedFreshness unknown

Data as of Dec 23, 2021, 6:25 PM UTC · policy pm-quality-3

Current implied probability

Market quality

14 / 100

Low quality

24h Volume

—

Liquidity

—

Liquidity unknown

Traders

Market data

Updated 1,763 days ago

Stale

Trends

Merck and Ridgeback Biotherapeutics'

Lost

Pfizer's

Won

Roche and Atea Pharmaceuticals'

Lost

None of them will be approved by the end of 2022

Lost

Rules

Resolution criteria are not yet available for this market. Refresh cycles will populate this section when source rules are stored.

Use this market in code or an AI agent